Tetrac and NDAT Induce Anti-Proliferation via Integrin Αvβ3 in Colorectal Cancers With Different K-Ras Status

Frontiers in Endocrinology - Switzerland
doi 10.3389/fendo.2019.00130
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Inhibition of Pathological Retinal Angiogenesis by the Integrin Αvβ3 Antagonist Tetraiodothyroacetic Acid (Tetrac)

Experimental Eye Research
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2012English

Targeting K-Ras Cancers

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2016English

Antisense Gene Therapy Using Anti-K-Ras and Antitelomerase Oligonucleotides in Colorectal Cancer

Revista Espanola de Enfermedades Digestivas
MedicineGastroenterology
2005English

Serum Amyloid a Promotes Osteosarcoma Invasion via Upregulating Αvβ3 Integrin

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2014English

K-Ras-Status Variabel

Im Focus Onkologie
2012English

Integrin Α3β1 (VLA-3); Integrin Α5β1; Integrin Αvβ3

Science-Business eXchange
2009English

P53 Expression and K-Ras Mutation in Colorectal Adenomas.

Gut
Gastroenterology
1993English

Individualisierte Therapie: K-Ras-Status Abklären

Info Onkologie
2011English

Role of Autophagy in K-Ras- And B-Raf-Driven Lung Cancers

Cancer & Metabolism
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy